In contrast, the percentage of CD103+CD39+CD8+ TILs was low in patients with microsatellite-stable colon cancer and colorectal liver metastasis, who tended to respond poorly to immunotherapy (69). This evidence concerns the gene ENTPD1 and malignant colon neoplasm.